Chiasma (Series E)
Funding Details
- Awarder
- Inbox
- Date Award
- March 02, 2015
- Vertical
- Biopharmaceuticals
- Funding URL
- View Funding Page
- Funding Amount:
- $70,000,000
Company Info
- Founders
- Roni Mamluk
- Company Description
- Chiasma is a biopharmaceutical company dedicated to improving the lives of patients with rare diseases by developing and commercializing oral medications that were previously available by injection only. The company's lead candidate is octreotide capsules, which has received orphan drug designation from the FDA and EMA.
- Market
- Rare diseases
- Location
- Newton Centre, MA, USA
- Coinvestors
- 7 Med Health Ventures, Abingworth, ARCH Venture Partners, F2 Capital, MPM Capital, Rock Springs Capital, Sofinnova Ventures